Boston Family Office »

Cyteir Therapeutics shares owned by Boston Family Office

Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by Boston Family Office from 13F filings

Historical chart of Boston Family Office investment in Cyteir Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyteir Therapeutics held by Boston Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyteir Therapeutics by Boston Family Office

Quarter filed Position value Share count Share price at filing
2024-03-31 $73k 24k 3.02
2023-12-31 $74k 24k 3.06
2023-09-30 $69k 24k 2.85
2023-06-30 $62k 24k 2.56